Simpson Manufacturing Co., Inc. (SSD) is a publicly traded Industrials sector company. As of May 21, 2026, SSD trades at $185.05 with a market cap of $7.49B and a P/E ratio of 21.38. SSD moved +3.98% today. Year to date, SSD is +9.40%; over the trailing twelve months it is +14.30%. Its 52-week range spans $137.35 to $211.98. Analyst consensus is buy with an average price target of $214.75. Rallies surfaces SSD's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Who owns SSD stock?
Hedge funds tracked by Rallies that own SSD include Valueact Holdings, Bridgewater Associates, and Pinebridge Investments. The latest tracked quarter is Mar 31, 2026. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Simpson Manufacturing Co., Inc..
SSD Key Metrics
Key financial metrics for SSD
Metric
Value
Price
$185.05
Market Cap
$7.49B
P/E Ratio
21.38
EPS
$8.56
Dividend Yield
0.30%
52-Week High
$211.98
52-Week Low
$137.35
Volume
428.94K
Avg Volume
0
Revenue (TTM)
$2.38B
Net Income
$355.42M
Gross Margin
45.49%
Top Hedge Funds Holding SSD
Valueact Holdings holds 1.40M shares of SSD, changed -5.03% as of Mar 31, 2026.
Bridgewater Associates holds 49.78K shares of SSD, changed -3.34% as of Dec 31, 2024.
Pinebridge Investments holds 4.40K shares of SSD, changed -62.56% as of Mar 31, 2025.
Hedge funds tracked by Rallies that own SSD include Valueact Holdings, Bridgewater Associates, and Pinebridge Investments. The latest tracked quarter is Mar 31, 2026. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Simpson Manufacturing Co., Inc..
Does Rallies show 13F holders for SSD?
Yes. Rallies tracks hedge fund and 13F ownership data for SSD, including fund names, share counts, latest tracked quarter, and position changes when available.
Is SSD research on Rallies investment advice?
No. Rallies provides research, data, and educational context for SSD. It does not provide personalized investment advice.